Connection

Kenji Takemoto to Liver

Back to Details
This is a "connection" page, showing publications Kenji Takemoto has written about Liver.
Kenji Takemoto
Connection Strength
0.059
Liver
  1. Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization. Toxicol Appl Pharmacol. 2020 06 01; 396:114982.
    View in: PubMed
    Score: 0.030
  2. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice. Free Radic Biol Med. 2019 12; 145:136-145.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.